Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study

BACKGROUND: Compared with conventional medicines, angiotensin receptor-neprilysin inhibitor (ARNI) could further improve the prognosis for multiple cardiovascular diseases, such as heart failure, hypertension, and myocardial infarction. However, the relationship between ARNI therapy and the recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Youzheng, Xiao, Shucai, He, Jinwu, Shi, Kaixin, Chen, Si, Liu, Deping, Huang, Bin, Zhai, Zhenyu, Li, Juxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386595/
https://www.ncbi.nlm.nih.gov/pubmed/35990986
http://dx.doi.org/10.3389/fcvm.2022.932780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386595/
https://www.ncbi.nlm.nih.gov/pubmed/35990986
http://dx.doi.org/10.3389/fcvm.2022.932780

Ejemplares similares